Why is the Nanosonics share price jumping 10% on Wednesday?

Nanosonics shares are jumping on Wednesday…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price is having a very strong day on Wednesday.

In afternoon trade, the infection prevention company's shares are up over 10% to $3.96.

Three businesspeople leap high with the CBD in the background.

Image source: Getty Images

What's going on with the Nanosonics share price?

Investors have been bidding the Nanosonics share price higher today despite there being no news out of the company.

However, it is worth highlighting that the healthcare sector is performing strongly today, as are a range of beaten down shares.

In respect to the former, in afternoon trade the S&P/ASX 200 Health Care index is up a sizeable 2%. That's despite the ASX 200 index trading 0.5% at the time of writing.

As for the latter, a number of beaten down ASX shares are recording double digit gains on Wednesday. This includes the likes of Life360 Inc (ASX: 360), Megaport Ltd (ASX: MP1), Mesoblast limited (ASX: MSB), and Zip Co Ltd (ASX: ZIP).

Some investors appear to believe that the selling has been overdone and now is the time to pounce.

Anything else?

Nanosonics is one of the most shorted shares on the Australian share market. At the last count, the company had over 12% of its shares in the hands of short sellers.

If some short sellers have decided to close positions, then they could be boosting the buy side by buying shares today.

Whatever the reason, with the Nanosonics share price still down ~40% in 2022, shareholders will no doubt be hoping there are more strong gains to come.

Motley Fool contributor James Mickleboro has positions in Life360, Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Inc., MEGAPORT FPO, Nanosonics Limited, and ZIPCOLTD FPO. The Motley Fool Australia has positions in and has recommended Nanosonics Limited. The Motley Fool Australia has recommended MEGAPORT FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a young scientist looking stressed out while working on a computer in a lab.
Broker Notes

What's Bell Potter's updated view on CSL shares?

Will the new tariffs impact CSL according to Bell Potter?

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Are Cogsgate shares a buy, hold or sell after rocketing 12% higher yesterday?

This broker thinks there could be more growth to come.

Read more »

woman in lab coat conducting testing.
Healthcare Shares

Is this battered ASX biotech stock ready to rocket higher?

Brokers are upbeat and see upside of up to 125%!

Read more »

young female doctor with digital tablet looking confused.
Healthcare Shares

Why are CSL shares struggling to regain momentum?

Analysts have widely considered the shares to be oversold for some time now.

Read more »

Happy man working on his laptop.
Healthcare Shares

This ASX healthcare stock is up 70% in a year and climbing again today

Another strong quarter keeps the Cogstate stock in focus.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

This ASX healthcare stock could more than double according to Canaccord Genuity

It's shaping up as a big year for this drug developer.

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Broker Notes

Why beaten down CSL shares now offer 'long-term appeal'

A leading expert gives his outlook for CSL’s beaten down shares.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Healthcare Shares

Why Neuren shares are rebounding on Wednesday after a brutal 2026 sell-off

Neuren shares jump after DAYBUE STIX expands across the US.

Read more »